Long-coronavirus disease 2019 (COVID-19) represents a heterogeneous clinical syndrome
characterized by a pathologic continuum of signs, symptoms, and also laboratory/radiologic …

Background Venous thromboembolism (VTE)(pulmonary embolism [PE] or deep venous
thrombosis [DVT]) is common during acute COVID-19. Long-term excess risk has not yet …

Thrombosis is one of the many signs of antiphospholipid syndrome (APS) and COVID-19
infection. Although the mechanisms contributing to thrombosis in APS and COVID-19 are …

Importance Immune-mediated inflammatory diseases (IMIDs) and COVID-19 are
independently associated with venous thromboembolisms (VTEs). Objective To determine if …

Importance The overall effects of vaccination on the risk of cardiac, and venous and arterial
thromboembolic complications following COVID-19 remain unclear. Objective We studied …

The role of the Corporate Medical Director (CMD) has received increased attention during
the COVID-19 pandemic and has continued to evolve. This updated guidance addresses the …

We sought to assess the sex-and age-specific trends in venous thromboembolism (VTE)
mortality in the 27 European Union Member States (EU-27) between years 2012 and 2020 …

Aims Previous studies suggest relatively increased cardiovascular risk after COVID-19
infection. This study assessed incidence and explored individual risk and timing of …

Persistent symptoms are common after acute COVID-19, often referred to as long COVID.
Long COVID may affect the ability to perform activities of daily living, including work. Long …

Abstract Background Coronavirus disease 2019 (COVID-19) has been proved as a
significant risk factor for deep vein thrombosis (DVT) after several waves of pandemic. This …